Description
Vidalista black (tadalafil) 80 mg
Vidalista black is identified here as a tadalafil-containing tablet product. Tadalafil is a prescription phosphodiesterase type 5 (PDE5) inhibitor used for erectile dysfunction, and in some regulatory labels also for benign prostatic hyperplasia. The supplied product name and strength should be treated as identification details only; the verified medicine component is tadalafil.
Active Ingredient and Medicine Class
The active ingredient is tadalafil, a PDE5 inhibitor. This class works by enhancing the nitric-oxide/cGMP pathway involved in smooth-muscle relaxation and blood flow in erectile tissue.
Established Medical Uses
Official prescribing information for tadalafil tablets includes treatment of erectile dysfunction. Some approved products and labels also include benign prostatic hyperplasia and combined erectile dysfunction/benign prostatic hyperplasia indications. The exact approved use depends on the specific regulated product and market authorization.
How It Works
Tadalafil inhibits PDE5, an enzyme that breaks down cyclic guanosine monophosphate (cGMP). By preserving cGMP, it helps support smooth-muscle relaxation and increased blood flow in the penis during sexual stimulation. It does not produce an erection on its own.
Important Safety Information
Tadalafil must not be used with nitrates or guanylate cyclase stimulators because of the risk of marked blood-pressure lowering. It is also contraindicated in people with hypersensitivity to tadalafil. Caution is needed in patients with cardiovascular disease, low blood pressure, renal or hepatic impairment, and when used with alpha-blockers, antihypertensives, potent CYP3A4 inhibitors, or substantial alcohol intake. Combined use with other PDE5 inhibitors or other erectile dysfunction therapies is not recommended.
Possible Side Effects
Common adverse effects reported with tadalafil include headache, dyspepsia, back pain, muscle pain, nasal congestion, flushing, and dizziness. Serious reactions can include prolonged erection or priapism, sudden vision loss, sudden hearing loss, and symptomatic hypotension.
Scientific Evidence
Peer-reviewed reviews and meta-analyses have found tadalafil effective for erectile dysfunction across a range of severities and causes, with a long duration of action that can extend the therapeutic window. Reviews also consistently describe headache and dyspepsia as common adverse effects, with back pain and myalgia also reported.
Medical Information Notice
This page is an educational summary based on sources available at the time of review. It does not replace the official patient leaflet, regulatory product information, or assessment by a qualified healthcare professional.
Medical Sources
- FDA / DailyMed: Tadalafil tablets, Full Prescribing Information
- Eric J H Meuleman et al. “Review of tadalafil in the treatment of erectile dysfunction.” Expert Opinion on Pharmacotherapy (2003). PubMed article
